https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
9%, respectively; p = 0.621). Differences in the rates of disease-free survival at 5 years were not statistically significant (79.0 and 80.5%, respectively; p = 0.624). This propensity score-matching analysis suggests that SBRT can be an alternative option to VATS lobectomy for stage I-II NSCLC. This propensity score-matching analysis suggests that SBRT can be an alternative option to VATS lobectomy for stage I-II NSCLC. To evaluate bladder cancer by integrating multiple imaging features acquired using multimodal 3.0T magne
Aimer
Commentaire
Partagez
